← Leaderboards
Michelle C Janelsins
University Of Rochester
$9,674,346
Attributed
$14,401,371
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,550,885 · 11
By mechanism
R01$7,550,669 · 3
T32$2,368,689 · 1
DP2$2,302,500 · 1
R25$895,696 · 1
K07$724,465 · 1
R21$367,249 · 1
Top collaborators
- Gary R Morrow9 shared
- Supriya G. Mohile6 shared
- Karen M Mustian6 shared
- Brian D Gonzalez2 shared
- Luke Joseph Peppone2 shared
- Brent John Small2 shared
- Jonathan W Friedberg1 shared
Most similar at University Of Rochester
Same institution · by research overlap
- Luke Joseph Peppone$4,817,736
- Allison Marian Magnuson$3,297,377
- Annalynn Williams$1,148,708
- Sara Lynn Montgomery$120,883
- Tongtong Wu$1,063,472
Others in their field
Top investigators on “Impaired Cognition”
- Michael W Weiner · Northern California Institute Res &Educ$154,600,259
- Paul S. Aisen · Cognition Therapeutics, Inc.$147,845,108
- Randall J Bateman · Washington University$143,423,124
- David A Bennett · Rush University Medical Center$100,504,767
- Reisa A. Sperling · Banner Health$99,367,151
- Eric Martin McDade · Washington University$94,632,845
Research focus
Impaired CognitionChemotherapyReportingCognitionCognitive FunctionInnovationBaseCognitiveCancer TherapyMediatingMalignant NeoplasmsSurvivorsClinical TrialsInflammationCommunity Clinical Oncology ProgramOncologyInflammatoryProgramsPsychologicCancer PatientChemobrainFutureLinkUniversities
Grant awards (35)
Optimizing Functional Outcomes of Older Survivors After Chemotherapy$676,601
R01 · FY2025 · CA
Impact of Targeted Therapy on Cancer-Related Cognitive Impairment$664,612
R01 · FY2025 · CA
Clinical and Translational Cancer Control Research Training Program$280,631
T32 · FY2025 · CA · contact PI
Developing a P01 to Address Cognitive Impairment and Treatment Tolerability in Patients with Advanced Cancer$149,514
P30 · FY2025 · CA
Human Biophysiology Shared Resource$78,324
P30 · FY2025 · CA · contact PI
Impact of Targeted Therapy on Cancer-Related Cognitive Impairment$700,049
R01 · FY2024 · CA
Optimizing Functional Outcomes of Older Survivors After Chemotherapy$678,850
R01 · FY2024 · CA
Translational Neuroscience Approaches to Cancer-Related Cognitive Impairment: Measurement, Mechanisms, and Function$489,500
R01 · FY2024 · CA · contact PI
Clinical and Translational Cancer Control Research Training Program$340,950
T32 · FY2024 · CA · contact PI
Optimizing Functional Outcomes of Older Survivors After Chemotherapy$703,412
R01 · FY2023 · CA
Translational Neuroscience Approaches to Cancer-Related Cognitive Impairment: Measurement, Mechanisms, and Function$504,959
R01 · FY2023 · CA · contact PI
Clinical and Translational Cancer Control Research Training Program$330,319
T32 · FY2023 · CA · contact PI
Translational Neuroscience Approaches to Cancer-Related Cognitive Impairment: Measurement, Mechanisms, and Function$504,959
R01 · FY2022 · CA · contact PI
Clinical and Translational Cancer Control Research Training Program$376,981
T32 · FY2022 · CA · contact PI
Translational Neuroscience Approaches to Cancer-Related Cognitive Impairment: Measurement, Mechanisms, and Function$515,263
R01 · FY2021 · CA · contact PI
Clinical and Translational Cancer Control Research Training Program$318,459
T32 · FY2021 · CA · contact PI
Optimizing Functional Outcomes of Older Survivors After Chemotherapy$293,330
R01 · FY2021 · CA
Optimizing Functional Outcomes of Older Survivors After Chemotherapy$770,000
R01 · FY2020 · CA
Translational Neuroscience Approaches to Cancer-Related Cognitive Impairment: Measurement, Mechanisms, and Function$416,414
R01 · FY2020 · CA · contact PI
Clinical and Translational Cancer Control Research Training Program$364,845
T32 · FY2020 · CA · contact PI
Translational Neuroscience Approaches to Cancer-Related Cognitive Impairment: Measurement, Mechanisms, and Function$632,720
R01 · FY2019 · CA · contact PI
Clinical and Translational Cancer Control Research Training Program$356,504
T32 · FY2019 · CA
Cancer Control Research Training Curriculum$455,585
R25 · FY2018 · CA
Cancer Control Research Training Curriculum$440,111
R25 · FY2017 · CA
Interventions Targeting Inflammation for Chemotherapy-Related Cognitive Problems$144,893
K07 · FY2017 · CA · contact PI
Interventions for Cognitive Impairment in Colorectal Cancer Patients$166,931
R21 · FY2016 · CA · contact PI
Interventions Targeting Inflammation for Chemotherapy-Related Cognitive Problems$144,893
K07 · FY2016 · CA · contact PI
Interventions for Cognitive Impairment in Colorectal Cancer Patients$200,318
R21 · FY2015 · CA · contact PI
Interventions Targeting Inflammation for Chemotherapy-Related Cognitive Problems$144,893
K07 · FY2015 · CA · contact PI
Clinical and Translational Approaches to Cognitive Impairments in Cancer$2,302,500
DP2 · FY2014 · CA · contact PI
Interventions Targeting Inflammation for Chemotherapy-Related Cognitive Problems$144,893
K07 · FY2014 · CA · contact PI
Interventions Targeting Inflammation for Chemotherapy-Related Cognitive Problems$144,893
K07 · FY2013 · CA · contact PI
Modulating Disease in Alzheimer's Disease Models$27,964
F31 · FY2007 · NS · contact PI
Modulating Disease in Alzheimer's Disease Models$43,351
F31 · FY2006 · NS · contact PI
Modulating Disease in Alzheimer's Disease Models$42,464
F31 · FY2005 · NS